|Bid||5.79 x 900|
|Ask||6.12 x 4000|
|Day's Range||5.87 - 6.09|
|52 Week Range||2.71 - 7.94|
|Beta (5Y Monthly)||1.17|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cerus Corporation (Nasdaq:CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, and Kevin D. Green, Cerus’ chief financial officer, are scheduled to participate in the following two conferences:
Cerus Corporation (Nasdaq:CERS) announced today that INTERCEPT Blood Systems disposable kit shipments have surpassed 7.5 million treatable platelet and plasma doses globally since commercial launch.
Cerus Corporation (Nasdaq: CERS) today announced financial results for the second quarter ended June 30, 2020.